ResMed Inc (RSMDF) balance sheet

RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value

$22.61+0.00 (0.00%)

Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%

ResMed Inc balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-06-30	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30	FY 2020 2020-06-30	FY 2019 2019-06-30	FY 2018 2018-06-30	FY 2017 2017-06-30	FY 2016 2016-06-30	FY 2015 2015-06-30	FY 2014 2014-06-30	FY 2013 2013-06-30	FY 2012 2012-06-30	FY 2011 2011-06-30	FY 2010 2010-06-30	FY 2009 2009-06-30	FY 2008 2008-06-30
Cash & Equivalents	1,469	1,209	238	228	274	295	463	147	189	822	731	717	906	876	810	735	489	416	321
Cash & Short-Term Investments	1,469	1,209	238	228	274	295	463	147	189	822	731	717	906	876	810	735	489	416	321
Receivables	1,036	939	837	705	576	614	475	528	484	451	382	363	360	318	283	274	227	–	–
Inventory	946	928	822	998	744	457	417	350	269	268	224	247	165	146	174	201	186	–	–
Prepaid Expenses & Other	416	429	460	437	338	208	75	120	125	103	82	81	94	61	–	–	–	–	–
Other Current Assets	185	164	142	180	131	129	–	–	–	–	–	–	–	61	72	59	65	–	–
Total Current Assets	4,325	3,506	2,358	2,368	1,931	1,575	1,523	1,145	1,066	1,644	1,420	1,408	1,556	1,449	1,361	1,292	985	–	–
Property, Plant & Equipment	582	551	548	538	498	463	417	387	387	394	384	388	434	411	434	462	387	–	–
Gross Property, Plant & Equipment	1,333	1,256	1,275	1,206	1,131	1,086	969	899	861	851	799	770	843	772	769	763	625	–	–
Accumulated Depreciation	-751	-705	-727	-668	-633	-622	-552	-512	-474	-456	-414	-382	-408	-361	-334	-301	-238	–	–
Equity Method Investments	77	76	65	65	9.92	17	14	22	0	38	–	–	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	153	167	151	128	132	129	118	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	2,910	3,047	2,842	2,770	1,936	1,928	1,890	1,856	1,069	1,065	1,059	264	289	275	256	235	199	–	–
Intangible Assets	453	465	486	552	346	393	448	522	215	262	300	47	45	50	55	48	31	–	–
Deferred Tax Assets	–	–	–	–	–	–	–	45	54	62	55	46	19	20	24	19	19	–	–
Other Long-Term Assets	215	186	284	262	172	161	149	151	274	42	38	28	17	5.92	7.82	12	5.32	–	–
Total Assets	8,966	8,174	6,872	6,752	5,096	4,728	4,587	4,108	3,064	3,468	3,257	2,182	2,361	2,211	2,138	2,069	1,626	–	–
Accounts Payable	309	278	238	151	159	138	136	116	93	93	93	81	85	61	55	55	58	–	–
Accrued Expenses	495	402	378	366	345	321	270	266	186	186	157	133	131	138	127	104	81	–	–
Short-Term Debt	260	9.90	9.90	9.90	9.92	12	12	12	11	–	299	–	–	–	–	–	–	–	–
Current Portion of Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	0.02	300	0.05	0.16	122	–	–
Current Debt	260	9.90	9.90	9.90	9.92	12	12	12	11	–	299	–	0.02	300	0.05	0.16	122	–	–
Current Portion of Leases	29	31	25	22	22	24	21	–	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	98	132	108	72	45	308	65	73	160	29	39	16	10	30	28	3.93	23	–	–
Deferred Revenue (Current)	163	166	153	138	109	110	99	89	61	52	50	36	42	45	42	45	30	–	–
Total Current Liabilities	1,395	1,019	911	759	689	912	603	556	511	360	638	266	270	574	253	209	313	–	–
Long-Term Debt	–	–	–	–	–	–	–	–	–	1,079	873	301	301	0.77	251	100	0	–	–
Long-Term Leases	137	153	141	117	120	115	102	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	167	184	167	139	142	138	123	–	–	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	–	–	–	–	–	–	–	11	13	14	9.06	6.37	11	9.90	8.84	8.05	11	–	–
Other Long-Term Liabilities	213	142	42	68	5.97	6.80	8.35	2.06	0.92	2.43	1.21	–	–	–	–	–	–	–	–
Total Liabilities	2,381	2,207	2,008	2,622	1,735	1,842	2,090	2,035	1,005	1,508	1,562	594	603	600	530	338	339	–	–
Total Debt	260	9.90	9.90	9.90	9.92	12	12	12	11	1,079	1,173	301	301	301	251	100	122	–	–
Preferred Stock	0	0	0	0	0	0	–	–	–	–	–	–	–	–	0	0	0	–	–
Additional Paid-In Capital	2,191	2,034	1,897	1,772	1,682	1,622	1,571	1,511	1,451	1,379	1,303	1,229	1,118	1,025	900	798	660	–	–
Retained Earnings	7,255	6,081	4,992	4,253	3,614	3,080	2,833	2,436	2,432	2,316	2,160	1,976	1,780	1,577	1,367	1,112	885	–	–
Treasury Stock	-2,779	-2,073	-1,773	-1,623	-1,623	-1,623	-1,623	-1,623	-1,600	-1,547	-1,547	-1,445	-1,292	-1,084	-896	-505	-345	–	–
Comprehensive Income & Other	-83	-75	-252	-273	-313	-193	-284	-253	-224	-189	-223	-174	152	92	236	324	86	–	–
Shareholders' Equity	6,585	5,968	4,864	4,130	3,361	2,886	2,497	2,072	2,059	1,960	1,695	1,587	1,758	1,611	1,608	1,731	–	–	–
Total Equity	6,585	5,968	4,864	4,130	3,361	2,886	2,497	2,072	2,059	1,960	1,695	1,587	1,758	1,611	1,608	1,731	1,288	1,115	1,082
Total Liabilities & Equity	8,966	8,174	6,872	6,752	5,096	4,728	4,587	4,108	3,064	3,468	3,257	2,182	2,361	2,211	2,138	2,069	1,626	–	–
Shares Outstanding(shares)	144	146	147	147	146	146	145	144	143	142	141	140	140	142	142	152	151	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 61.1%
Operating margin: 33.4%
Net margin: 26.9%
Return on equity, FY2026: 24.3%

Financial strength

Current ratio: 3.10
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 105.3%

Valuation

P/E ratio: 22.0
Price to sales: 5.87
Price to book: 5.04
Dividend yield: 1.04%